Hot Pursuit     17-Mar-25
Zydus Life gains as Gujarat facility clears USFDA inspection with zero observations
Zydus Lifesciences rose 1.67% to Rs 897.25 after the firm said that the US Food and Drug Administration (USFDA) conducted a surveillance inspection at the company’s Active Pharmaceutical Ingredient (API) Unit 1, located in Ankleshwar, Gujarat.

The said inspection was conducted from 10 March to 14 March 2025 and concluded with zero observations from the regulatory body.

The official announcement was made on 14 March 2025.

Zydus Lifesciences is a discovery-driven, global life sciences company that discovers, develops, manufactures, and markets a broad range of healthcare therapies.

The company reported a 29.62% jump in consolidated net profit of Rs 1,023.5 crore in Q3 FY25 compared with Rs 789.6 crore in Q3 FY24. Revenue from operations increased 16.96% YoY to Rs 5,269.1 crore during the quarter.

Previous News
  Zydus Lifesciences
 ( Analyst Meet / AGM - Conference Call 10-Feb-26   11:38 )
  Zydus Lifesciences
 ( Results - Analysis 09-Feb-26   15:39 )
  Zydus Lifesciences consolidated net profit rises 1.82% in the December 2025 quarter
 ( Results - Announcements 09-Feb-26   16:59 )
  Zydus receives USFDA Orphan drug designation for Desidustat
 ( Corporate News - 06-Feb-26   12:45 )
  Zydus receives USFDA tentative approval for Dapagliflozin Tablets
 ( Corporate News - 04-Feb-26   16:07 )
  Zydus Lifesciences to discuss results
 ( Corporate News - 28-Jan-26   10:46 )
  Zydus Lifesciences' Ankleshwar unit completes USFDA inspection
 ( Corporate News - 24-Jan-26   10:51 )
  Zydus Lifesciences launches world's first biosimilar of Nivolumab in India
 ( Corporate News - 22-Jan-26   12:54 )
  Zydus Lifesciences rises after launching nivolumab biosimilar
 ( Hot Pursuit - 22-Jan-26   10:09 )
  Sentynl (Zydus Group) receives USFDA approval for ZYCUBO®
 ( Corporate News - 13-Jan-26   14:01 )
  Zydus Lifesciences’ US arm secures FDA nod for ZYCUBO in Pediatric Menkes Patients
 ( Hot Pursuit - 13-Jan-26   11:17 )
Other Stories
  Pearl Global Industries Ltd leads losers in 'A' group
  10-Feb-26   15:00
  Khandwala Securities Ltd leads losers in 'B' group
  10-Feb-26   14:45
  Volumes soar at Pfizer Ltd counter
  10-Feb-26   14:30
  Nelcast soars after Q3 PAT soars 166.1% YoY
  10-Feb-26   14:27
  Gulf Oil Lubricants records PAT of Rs 76.13 crore in Q3; EBITDA rises 7.80% YoY
  10-Feb-26   13:38
  Shanti Gold International posts PAT of Rs 40.08 crore in Q3
  10-Feb-26   13:25
  Happiest Minds records over 25% sequential drop in Q3 PAT
  10-Feb-26   13:08
  Kotak Mahindra Bank Ltd spurts 1.11%, gains for third straight session
  10-Feb-26   13:05
  Mahindra & Mahindra Ltd spurts 2.08%, gains for third straight session
  10-Feb-26   13:05
  BSE Ltd gains for third consecutive session
  10-Feb-26   13:05
Back Top